EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
about
Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancerCo-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells.When Palliative Treatment Achieves More Than Palliation: Instances of Long-term Survival after Palliative Radiotherapy[EGFR-dependent impact of indol-3-carbinol on radiosensitivity of lung cancer cells].
P2860
EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
@en
EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
@nl
type
label
EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
@en
EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
@nl
prefLabel
EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
@en
EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
@nl
P2093
P2860
P356
P1476
EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells.
@en
P2093
Junjie Wang
Ruijie Yang
Yingdong Zhang
Zhenyu You
P2860
P2888
P356
10.1186/1475-2867-10-39
P577
2010-10-23T00:00:00Z
P5875
P6179
1039583177